curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

by palligoelme@gmail.com | Jun 30, 2025 | Clinical Trials

​ Conditions: Colorectal Cancer; Liver Metastases; Liver Cancer Interventions: Device: HistoSonics Edison® System; Drug: Chemotherapy Sponsors: Case Comprehensive Cancer Center; HistoSonics, Inc. Not yet recruiting Conditions: Colorectal Cancer; Liver Metastases;...

Intestinal Hyperechogenicity Confirmed by Evaluation of Gray Spectra

by palligoelme@gmail.com | Jun 30, 2025 | Clinical Trials

​ Conditions: Echogenicity; Intestinal Foetus Interventions: Other: Evaluation of echogenicity Sponsors: Hospices Civils de Lyon Not yet recruiting Conditions: Echogenicity; Intestinal Foetus Interventions: Other: Evaluation of echogenicity Sponsors: Hospices Civils...

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

by palligoelme@gmail.com | Jun 30, 2025 | Clinical Trials

​ Conditions: Endometrial Cancer; Malignant Solid Tumour Interventions: Drug: Puxitatug Samrotecan; Drug: Doxorubicin; Drug: Paclitaxel Sponsors: AstraZeneca Not yet recruiting Conditions: Endometrial Cancer; Malignant Solid Tumour Interventions: Drug: Puxitatug...

Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment

by palligoelme@gmail.com | Jun 30, 2025 | Clinical Trials

​ Conditions: Phantom Pain Following Amputation of Lower Limb; Amputation Interventions: Behavioral: Actiive Virtual Reality Treatment Sponsors: Albert Einstein Healthcare Network; University of Pennsylvania Recruiting Conditions: Phantom Pain Following Amputation of...

Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories

by palligoelme@gmail.com | Jun 27, 2025 | Clinical Trials

​ Conditions: Preeclampsia; Gestational Hypertension Interventions: Drug: spironolactone 25 mg orally once daily; Drug: Placebo tablet to match spironolactone Sponsors: Massachusetts General Hospital; Brigham and Women’s Hospital; University of Pittsburgh...
« Older Entries
Next Entries »

Recent Posts

  • Preventive Analgesia With Anrikefon in Laparoscopic Cholecystectomy
  • Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)
  • Efficacy and Safety of HA35 Gel for Mild Gingival Recession and Periodontal Inflammation: A Pilot Clinical Study
  • Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma Closure
  • Effect of Moulage-Based Performance on Violence Against Women Awareness

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®